Sort
39,280 grants matching “leukemia”
Terminal Transferase and Lymphocyte Development
$337,184John Franklin Kearney · University Of Alabama At Birmingham · R01 · FY2008 · AI
Immune Tolerance of CLL Antigens
$337,175John G. Gribben · University Of California, San Diego · P01 · FY2009 · CA
LIF and Cell Renewal in Hippocampus and Olfactory Bulb
$337,163California Institute Of Technology · R01 · FY2005 · NS
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
$337,136Michael R Green · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · CA
Clinical Trials Engine to Develop an HIV Cure study to test engineered T cells
$337,135Christina M Coughlin · University Of Pennsylvania · U19 · FY2022 · AI
Topoisomerase II Site-Directed Alkylation of DNA
$337,088University Of Arizona · R01 · FY2002 · CA
Genotoxicity &Emergence of Genome Instability in Humans
$337,088University Of Vermont &St Agric College · R01 · FY2005 · CA
Topoisomerase II Site-Directed Alkylation of DNA
$337,088University Of Arizona · R01 · FY2003 · CA
Topoisomerase II Site-Directed Alkylation of DNA
$337,088University Of Arizona · R01 · FY2005 · CA
Genotoxicity &Emergence of Genome Instability in Humans
$337,088University Of Vermont &St Agric College · R01 · FY2004 · CA
Topoisomerase II Site-Directed Alkylation of DNA
$337,088University Of Arizona · R01 · FY2004 · CA
t(8;21) and SON in Blood Cell Proliferation and Differentiation
$337,057Dong-Er Zhang · University Of California, San Diego · R01 · FY2013 · CA
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer
$337,055Thomas Westbrook · Baylor College Of Medicine · P50 · FY2022 · CA
STEM CELL SURVIVAL CLONAL ADAPTATION AND CARCINOGENESIS IN FANCONI ANEMIA
$337,044Grover Carlton Bagby · Oregon Health & Science University · P01 · FY2006 · HL
Modified Donor Lymphocytes Infusion (mDLI) for Rapid Immune Reconstitution
$337,040Edmund K. Waller · Emory University · P01 · FY2011 · HL
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation
$337,036Samuel Strober · Stanford University · P01 · FY2013 · HL
TUMOR CELL BIOLOGY OF THE FMS ONCOGENE PROTEINS
$337,036Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
Survival Mechanisms in Leukemic NK Cells
$337,029Thomas P Loughran · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · CA
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
$336,968Jonathan D. Licht · University Of Florida · R01 · FY2019 · CA
The role of reorganization energy in achieving selective kinase inhibition
$336,961John Damon Chodera · Sloan-Kettering Inst Can Research · R01 · FY2018 · GM
Novel TYRO3 inhibitors for treatment of cancer
$336,957Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Role of Gab2 in Mast Cell Function and Ontogeny
$336,927Beth Israel Deaconess Medical Center · R01 · FY2003 · AI
MCC Tumor-Specific Biomarkers: Basis for Rational Therapy of Merkel Cell Carcinom
$336,920Patrick S. Moore · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Clinical Significance of MHC Haplotypes in HCT
$336,873Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Genomics of Teatment-Related AML
$336,859Daniel C Link · Washington University · P01 · FY2016 · CA